Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  143,890 results for ""United States""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Non-FDA-Reviewed Imported European Formula Use Among Parents in Urban Pediatric Private Practice.

Subjects: Parents* ; Private Practice* ; United States Food and Drug Administration*

  • Source: Clinical pediatrics [Clin Pediatr (Phila)] 2020 Jun; Vol. 59 (6), pp. 566-572. Date of Electronic Publication: 2020 Mar 07.Publisher: Sage Publications Country of Publication: United States NLM ID: 0372606 Publication Model:

Record details

×
Academic Journal

Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.

  • Authors : Bhasale A; University of Sydney Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, 6W75, The Hub, Charles Perkins Centre D17, University of Sydney, NSW 2006, Australia .; Mintzes B

Subjects: Communication* ; Drug-Related Side Effects and Adverse Reactions* ; Risk*

  • Source: BMJ (Clinical research ed.) [BMJ] 2020 Apr 29; Vol. 369, pp. m1107. Date of Electronic Publication: 2020 Apr 29.Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Compatibility of immunogenicity guidance by the EMA and the US FDA.

  • Authors : Kurki P; University of Helsinki, Clinical Immunology, Lukupolku 19, FI-00680 Helsinki, Finland.

Subjects: Guidelines as Topic* ; Immunologic Techniques* ; United States Food and Drug Administration*

  • Source: Bioanalysis [Bioanalysis] 2019 Sep; Vol. 11 (17), pp. 1619-1629. Date of Electronic Publication: 2019 Jan 23.Publisher: Future Science Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Comparison of EMA and FDA Decisions for New Drug Marketing Applications 2014-2016: Concordance, Discordance, and Why.

  • Authors : Kashoki M; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; PAREXEL Consulting, PAREXEL International, Billerica, Massachusetts, USA.

Subjects: Drug Approval/Drug Approval/Drug Approval/*statistics & numerical data ; Government Agencies/Government Agencies/Government Agencies/*statistics & numerical data ; United States Food and Drug Administration/United States Food and Drug Administration/United States Food and Drug Administration/*statistics & numerical data

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Jan; Vol. 107 (1), pp. 195-202. Date of Electronic Publication: 2019 Aug 14.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model:

Record details

×
Report

Impact of Food and Drug Administration Regulatory Approach on the 0/2-Hour Algorithm for Rapid Triage of Suspected Myocardial Infarction.

  • Authors : Wildi K; Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology (K.W., T.N., D.W., J.B., P.B., L.K., P.D., M.R.G., R.T., C.M.), University Hospital Basel, University of Basel, Switzerland.; Critical Care Research Group, the Prince Charles Hospital, Brisbane, Australia (K.W.).

Subjects: Algorithms* ; Decision Support Techniques* ; Triage*

  • Source: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2019 Jan; Vol. 12 (1), pp. e005188.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101489148

Record details

×
  • 1-10 of  143,890 results for ""United States""